Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-25-001502
Filing Date
2025-12-10
Accepted
2025-12-10 20:53:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9854
  Complete submission text file 0001013594-25-001502.txt   11727
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1707
EXICURE, INC. (Subject) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90023 | Film No.: 251563300
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 22F, PARC.1, 108, YEOUI-DAERO YEONGDEUNGPO-GU SEOUL Korea, Republic of
Business Address 22F, PARC.1, 108, YEOUI-DAERO YEONGDEUNGPO-GU SEOUL Korea, Republic of 82-2-1566-0900
SANGSANGIN INVESTMENT & SECURITIES CO., LTD. (Filed by) CIK: 0002049712 (see all company filings)

EIN.: 980243728 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A